drugset / Trial / NCT01640691
Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
NaSingle-groupOpen-labelPrevention
Summary
The objectives of this single arm study are to evaluate the immune response and safety profiles of two injections of an inactivated whole-virion vaccine containing aluminum hydroxide adjuvant, AdimFlu-W (H5N1), against influenza A (H5N1) in healthy adults.
Timeline
- Start
- 2012-07-10
- Primary completion
- 2013-01-02
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AdimFlu-W (H5N1) | Vaccine | 0.5 ml | Intramuscular |